1. Home
  2. Clinical Topics
  3. FDA expands approved use of drug to treat liver cancer
Clinical TopicsDrugs and DevicesNewsOncologyWeb Exclusives

FDA expands approved use of drug to treat liver cancer

Share

On April 27, the U.S. Food and Drug Administration (FDA) expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma who have been previously treated with the drug sorafenib. It’s the first FDA-approved treatment for a liver cancer in almost a decade. Read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts